JAK mutations in high-risk childhood acute lymphoblastic leukemia

Charles G. Mullighan(St. Jude Children's Research Hospital), Cheryl L. Willman(University of New Mexico)

Proceedings of the National Academy of Sciences

May 22, 2009

10.1073/pnas.0811761106

Cited by 559

Related Papers

Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia

|New England Journal of Medicine|2009|1.4k

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

|PubMed|1999|579

The genetic basis and cell of origin of mixed phenotype acute leukaemia

|Nature|2018|367

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

|Nature Communications|2016|293

Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL

|JCI Insight|2016|59